• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Adenocard (adenosine) 3 mg/mL injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – November 2009

 

Summary View

 

WARNINGS

Arrhythmias at Time of Conversion
  • They generally last only a few seconds without intervention, and may take the form of premature...atrial fibrillation